PL337003A1 - Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs - Google Patents

Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs

Info

Publication number
PL337003A1
PL337003A1 PL98337003A PL33700398A PL337003A1 PL 337003 A1 PL337003 A1 PL 337003A1 PL 98337003 A PL98337003 A PL 98337003A PL 33700398 A PL33700398 A PL 33700398A PL 337003 A1 PL337003 A1 PL 337003A1
Authority
PL
Poland
Prior art keywords
caprophen
cox
dogs
selectively acting
inflammatory states
Prior art date
Application number
PL98337003A
Other languages
English (en)
Inventor
Krystin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL337003A1 publication Critical patent/PL337003A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
PL98337003A 1997-05-05 1998-05-01 Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs PL337003A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (fr) 1997-05-05 1998-05-01 Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens

Publications (1)

Publication Number Publication Date
PL337003A1 true PL337003A1 (en) 2000-07-31

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337003A PL337003A1 (en) 1997-05-05 1998-05-01 Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
WO2000024393A1 (fr) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Produit de combinaison comprenant un ligand de prostaglandine de type e et un inhibiteur selectif de cox-2, et procedes d'utilisation dudit produit
EP1637137A3 (fr) * 1999-03-10 2006-07-05 G.D. Searle LLC Méthode et composition se rapportant à l'administration d'un inhibiteure de la cyclooxygénase-2 aux animaux
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
EP1296665B1 (fr) 2000-06-13 2011-06-08 Wyeth LLC Compositions analgesiques et anti-inflammatoires a base de celecoxib et d'ibuprofene
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
AU8475301A (en) 2000-08-07 2002-02-18 Univ Vanderbilt Detection of cox-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
AU2004237439B2 (en) 2003-05-07 2009-09-10 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
BRPI0412581A (pt) * 2003-07-31 2006-09-19 Pharmacia & Upjohn Co Llc formulação dispersável de um agente antiinflamatório
WO2006123247A2 (fr) * 2005-05-20 2006-11-23 Pfizer Limited Combinaisons synergiques
JP5553747B2 (ja) 2007-04-04 2014-07-16 シグモイド・ファーマ・リミテッド シクロスポリン医薬組成物
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
PL2471518T3 (pl) 2009-05-18 2018-01-31 Sigmoid Pharma Ltd Kompozycja zawierająca kropelki oleju
CA2770570A1 (fr) 2009-08-12 2011-02-17 Sigmoid Pharma Limited Compositions immunomodulatrices comprenant une matrice polymere et une phase huileuse
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
TWI664969B (zh) * 2014-03-06 2019-07-11 雅瑞塔那醫療公司 格拉匹綸(ｇｒａｐｉｐｒａｎｔ)組合物及其使用方法
SI3215127T1 (sl) 2014-11-07 2021-03-31 Sublimity Therapeutics Limited DCU Alpha Innovation Campus Sestavki, obsegajoči ciklosporin
US20180264061A1 (en) * 2015-01-09 2018-09-20 Jaguar Animal Health Methods of Treating Diarrhea in Companion Animals
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
AP9801234A0 (en) 1999-11-04
HRP980244A2 (en) 1999-02-28
OA11213A (en) 2003-07-14
GT199800063A (es) 1999-10-26
NO995389D0 (no) 1999-11-04
IS5220A (is) 1999-10-19
AR011726A1 (es) 2000-08-30
AR039628A2 (es) 2005-03-02
SK148199A3 (en) 2001-09-11
CA2288759A1 (fr) 1998-11-12
KR20040004406A (ko) 2004-01-13
PE72599A1 (es) 1999-08-12
NO995389L (no) 2000-01-04
DZ2479A1 (fr) 2003-02-01
TW590773B (en) 2004-06-11
IL132570A0 (en) 2001-03-19
ZA983722B (en) 1999-11-04
MA26491A1 (fr) 2004-12-20
PA8450601A1 (es) 2000-05-24
BR9808720A (pt) 2000-07-11
BG103852A (en) 2000-06-30
NZ500183A (en) 2002-04-26
YU55899A (sh) 2003-08-29
CN1255059A (zh) 2000-05-31
ID21311A (id) 1999-05-20
EA199900895A1 (ru) 2000-06-26
EA003696B1 (ru) 2003-08-28
WO1998050033A1 (fr) 1998-11-12
KR20010012300A (ko) 2001-02-15
EP0988034A1 (fr) 2000-03-29
TNSN98059A1 (fr) 2005-03-15
HUP0001286A2 (hu) 2000-11-28
JP2000513020A (ja) 2000-10-03
AU6932198A (en) 1998-11-27
UY24989A1 (es) 2001-10-25
HUP0001286A3 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
PL337003A1 (en) Caprophen selectively acting on cox-2 in treating pains and inflammatory states among dogs
PL336758A1 (en) Substituted imidazoles useful in treating inflammatory states
HUP0004484A3 (en) Desaturase genes and their use
ATE318746T1 (de) Lasttragende und steuerbare einheit
HK1027917A1 (en) Power amplifier and method therein
EP0923690A4 (fr) Systeme integre de puissance et de commande
DE69836460D1 (de) Übertragungsgerät und Lastverteilungsübertragungsverfahren im Übertragungsgerät
PL337665A1 (en) (s) 2-methylamine-2-phenyl-n-butyl-3,4,5-trimethoxybezoate and application thereof in treating long-lasting pains
EP0980261A4 (fr) Methodes de prevention et de traitement du desequilibre metabolique induit par insulte chez les humains et des animaux
GB2328299B (en) Data-processing device and method
AU5871898A (en) Microparticles and their use in cancer treatment
DE69628756D1 (de) Kombinierte longitudinale und transversale Spurnachführung
GB9624587D0 (en) Improvements in and relating magnetic bearings
GB9625666D0 (en) Improvements in construction and control
ZA972543B (en) Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
AU7334398A (en) Transgenic animal with controllable hyperproliferation and inflammation phenotype in the skin
BR7601188U (pt) Disposiçao introduzida em carteira
PL339804A1 (en) Application of thiazolydine diones in treating hyperglycaemia
BR9705337A (pt) Aperfeiçoamento introduzidos em duchas chuveiros eletricos e outros
GB9726490D0 (en) Hydraulic power arrangement and method
GB9603168D0 (en) Microorganisms and their use in treating silage
BR7600753U (pt) Disposição construtiva em picador liquidificador - sistema de acionamento e arraste
AU1374599A (en) Materials and methods for preventing cellular injury in humans and animals
GB9818018D0 (en) Microparticles and their use in therapy
ES1029493Y (es) Perfeccionamientos en dispositivos de tratamiento de aguas y disoluciones.